Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Blood Advances|December 22, 2020
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AMLNicholas J Short, Hind Rafei, Naval Daver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown PrimaryKanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
Journal of the National Cancer Institute|May 18, 2023
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling studyRyan W Huey, Aakash Tushar Shah, Honey V Reddi, et al.
Stroke|June 12, 2019
Emergency Department Door-to-Puncture Time Since 2014Alexandra L Czap, James C Grotta, Stephanie A Parker, et al.
Annals of Surgery|June 13, 2019
Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction AdenocarcinomaKazuto Harada, Hyunsoo Hwang, Xuemei Wang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 30, 2020
Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastasesKazuto Harada, Hyunsoo Hwang, Xuemei Wang, et al.
Journal of Hematology & Oncology|June 27, 2026
Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II studyNicholas J Short, Alex Bataller, Courtney D DiNardo, et al.
Annals of Surgery|May 27, 2025
Repeat Versus Single Quadratus Lumborum Block to Reduce Opioids After Open Pancreatectomy (RESQU-BLOCK): A Randomized Clinical TrialBrittany C Fields, Jose M Soliz, Barbra Bryce Speer, et al.
The Lancet. Oncology|February 5, 2026
Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaborationChad Tang, Alex D Sherry, Hyunsoo Hwang, et al.
Blood Cancer Discovery|February 12, 2026
Ibrutinib with venetoclax in patients with relapsed/refractory chronic lymphocytic leukemia: A phase II studyMahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson, et al.
Pageof 5